We invite you to our eagerly awaited third MSA Research Symposium!

Whether you are an established professional or an early career researcher, this symposium offers a unique platform to exchange knowledge and provide ample opportunities for networking where ideas can be shared, and potential research collaborations can be explored. Doctors looking to enhance their expertise in diagnosing and managing Multiple System Atrophy (MSA) are warmly invited to participate. The sessions will delve into diverse aspects of MSA diagnosis and management in this year’s symposium, with a focus on the prodromal stage. Specialists in neurology, urology, autonomic, respiratory, and sleep medicine, engaged in MSA patient care, are encouraged to join. Our speakers include Dr. Horacio Kaufmann, Professor of Neurology at NYU Langone Health; Professor Tom Foltynie, Professor of Neurology; and Andrew Singleton, Director of the National Institutes of Health (US).

Speakers

Doctor Andrew Singleton National Institute of Health (US)

Andrew Singleton earned his B.Sc. from the University of Sunderland and his Ph.D. from the University of Newcastle upon Tyne, UK, focusing on the genetic determinants of Alzheimer’s disease and dementia with Lewy bodies. He completed postdoctoral studies at the Mayo Clinic in Florida before joining the National Institute on Aging at the NIH in 2001. Currently, Andrew is an NIH Distinguished Investigator and Director of the Center for Alzheimer’s and Related Dementias at the NIH.

He has published over 700 articles on the genetic basis of neurodegenerative disorders. His work aims to identify genetic variants that cause or contribute to these diseases and to understand the molecular mechanisms underlying them. Among his many honors, Andrew received the 2024 Breakthrough Prize in Life Sciences.

Professor Tom Foltynie Professor of Neurology, UCL National Hospital for Neurology & Neurosurgery

Professor Tom Foltynie is a Professor of Neurology at UCL Institute of Neurology and Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, London. He specialises in advanced treatments for Parkinson’s disease (PD), including Deep Brain Stimulation (DBS), Apomorphine, and Duodopa. As Chief Investigator, he leads trials on Exenatide, gene therapy, and cell therapy for PD, and oversees the Edmond J. Safra Accelerating Clinical Trials in PD project. His research includes DBS for cognitive issues in PD/DLB and severe Tourette syndrome. He trained at UCL, completed his PhD on PD heterogeneity in Cambridge, and became Professor in 2016.

Professor Horacio Kaufmann Professor of Neurology, NYU Langone Health

Professor Wassilios Meissner Professor of Neurology, Department of Neurology for Neurodegenerative Diseases, University Hospital Bordeaux

Professor Zane Jaunmuktane University College London

Professor Vincenzo Libri Professor of Translational Neurology, University College London

Billing Information

Name

Credit Card

Visa
Mastercard
American Express
Discover

Address

Mobile Phone Number

MSA Research Symposium

Friday, 25th April 2025, at the UCL Great Ormond Street Institute of Child Health

We invite you to our eagerly awaited third MSA Research Symposium!

Countdown:

NaN days, NaN hours, NaN minutes, NaN seconds